Oncodigm BioPharma (NASDAQ: ONTY) (TSX: ONY)

Liposomal formulation of recombinant IL-2 for use as chemotherapy or cancer vaccine adjuvant.

Get a Demo and See the Full Profile

Get a demo today to see profiles of Oncodigm BioPharma (NASDAQ: ONTY) (TSX: ONY) plus 5979 other startups.

Learn More About Oncodigm BioPharma (NASDAQ: ONTY) (TSX: ONY)

Technology/product details

Competing Startups

More